CTRI/2021/05/033784
Recruiting
N/A
Clinical Efficacy & Neurobiological Correlates of sequential treatment with cathodal tDCS primed iTBS and ECT in Treatment-Resistant Depression
Department of Psychiatry National Institute of Mental Health and Neuro Sciences0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: F33- Major depressive disorder, recurrentHealth Condition 2: F32- Major depressive disorder, singleepisode
- Sponsor
- Department of Psychiatry National Institute of Mental Health and Neuro Sciences
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Major Depressive Disorder Diagnosis (DSM\-5\)
- •2\.Right\-handed (Edinburgh Handedness Inventory)
- •3\.Hamilton Depression Rating Scale (HAMD\-17\) score of 18 or more
- •4\.No clinical response to an adequate dose of two antidepressant medications (based on antidepressant treatment history form score) OR Unable to tolerate at least two separate trials of antidepressants of inadequate dose and duration, and if they are currently on a stable antidepressant regimen for at least 4 weeks before which will be continued during treatment
- •5\.Capacity to consent for research studies as per the assessment using the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC)
- •6\. Written informed consent.
Exclusion Criteria
- •1\.Resistant to 3 or more antidepressants or to an adequate ECT trial
- •2\.Suicidal intent (HAMD suicide item score of 3 or 4\) / any psychiatric emergency
- •3\.Bipolar depression;
- •4\.Psychotic disorder or symptoms;
- •5\.Neurological/clinical evidence of other medical comorbidity that could substantially influence depression;
- •6\.Unstable medical illness;
- •7\.Co\-prescribed BZD \>1\-mg clonazepam equivalents or anti\-epileptic drugs;
- •8\.Severe general medical/neurological comorbidity that precludes ECT or has an effect on cognition and behavior;
- •9\.Current psychoactive substance dependence (except caffeine or nicotine);
- •10\.Pregnancy or Post\-partum Period;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A study to assess efficacy of Electroconvulsive Therapy (ECT) in schizophrenia patients who have not responded/tolerated ClozapineHealth Condition 1: F20- SchizophreniaCTRI/2021/05/033775Department of Psychiatry National Institute of Mental Health and Neuro Sciences
Not Yet Recruiting
N/A
Clinical and neurophysiological effectiveness features of neurorehabilitation in cerebrovascular aphasiaR47.0I63.5Dysphasia and aphasiaCerebral infarction due to unspecified occlusion or stenosis of cerebral arteriesDRKS00030008Klinik Bavaria Kreischa GmbH50
Recruiting
Phase 1
Clinical Trials for Chronic Urticariachronic urticariaITMCTR2100004975Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Recruiting
N/A
The Neurological and Clinical Effects of Game Therapy in Fibromyalgia PatientsFibromyalgiaChronic PainFatigueParesthesiaIrritable Bowel SyndromeAnxietyDepression.C05.651.324C23.888.592.612.274C23.888.369C10.597.751.791.875C06.405.469.158.272.608F01.470.132F01.145.126.350RBR-8jdbrmniversidade Federal de Sergipe
Not Yet Recruiting
Early Phase 1
Clinical efficacy observation and effect brain region study of acupuncture treatment of depersonalization-derealization disorder by regulating yin and yangdepersonalization-derealization disorder6B66ITMCTR2024000233Beijing Anding Hospital, Capital Medical University